1,25-Dihydroxyvitamin D3 decreases podocyte loss and podocyte hypertrophy in the subtotally nephrectomized rat

American Journal of Physiology - Renal Physiology

Volumn 286, Issue 3 55-3, 2004, Pages

  Kuhlmann, Alexander ^a   Haas, Christian S ^a   Gross, Marie Luise ^b   Reulbach, Udo ^a   Holzinger, Marc ^a   Schwarz, Ute ^b   Ritz, Eberhard ^b   Amann, Kerstin ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^b UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Glomerular endothelial cell; Mesangial cell; Progression; Visceral glomerular epithelial cell

Indexed keywords

ALBUMIN; CALCITRIOL; CREATININE; CYCLINE; DESMIN; PROTEIN P27; WT1 PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD PRESSURE MEASUREMENT; CELL COMPOSITION; CELL HYPERPLASIA; CONTROLLED STUDY; DRUG MECHANISM; ENDOTHELIUM CELL; GLOMERULAR STRUCTURE; GLOMERULUS EPITHELIUM; IMMUNOHISTOCHEMISTRY; IMMUNOHISTOLOGY; MALE; MESANGIUM CELL; NEPHRECTOMY; NONHUMAN; PODOCYTE; PRIORITY JOURNAL; PROTEINURIA; RAT; STEREOLOGY;

EID: 1242351768     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.00316.2003     Document Type: Article

References (55)

1. Amann K, Nichols C, Törnig J, Schwarz U, Zeier M, Mall G, and Ritz E. Effect of ramipril, nifedipine, and moxonidine on glomerular morphology and podocyte structure in experimental renal failure. Nephrol Dial Transplant 11: 1003-1111, 1996.
2. 3. Clin Exp Immunol 94: 412-417, 1993.
3. 3 inhibits proliferation and increases c-myc expression in fibroblasts from psoriatic patients. J Endocrinol Invest 21: 520-525, 1998.
4. 1 integrin on podocytes of human and rats with diabetes. Life Sci 67: 2345-2353, 2000.
5. Coimbra TM, Janssen U, Gröne HJ, Ostendorf T, Kunter U, Schmidt H, Brabant G, and Floege J. Early events leading to renal injury in obese Zucker (fatty) rats with type II diabetes. Kidney hit 57: 167-182, 2000.
6. 1 integrins. Kidney Int 42: 1099-1106, 1992.
7. DeLuca HF. The vitamin D story: a collaborative effort of basic science and clinical medicine. FASEB J 2: 224-236, 1988.
8. Floege J, Alpers CE, Sage EH, Pritzl P, Gordon K, Johnson RJ, and Couser WG. Markers of complement-dependent and complement-independent glomerular visceral epithelial cell injury in vivo. Expression of antiadhesive proteins and cytoskeletal changes. Lab Invest 67: 486-497, 1992.
9. Fries JW, Sandstrom DJ, Meyer TW, and Rennke HG. Glomerular hypertrophy and epithelial cell injury modulate progressive glomerulosclerosis in the rat. Lab Invest 60: 205-218, 1989.
10. Gross ML, El-Shakmak A, Ziebart H, Szábó A, Koch A, Simonaviciene A, Kuhlmann A, Münter K, Ritz E, and Amann K. ACE inhibitors but not endothelin receptor blockers prevent podocyte loss in early diabetic nephropathy. Diabetologia 46: 856-868, 2003.
11. Gundersen HJ. Stereology of arbitrary particles. A review of unbiased number and size estimators and the presentation of some new ones, in memory of William R Thompson. J Microsc 143: 3-45, 1986.
12. 3 induces elevated expression of the cell cycle-regulating genes p21 and p27 in squamous carcinoma cell lines of the head and neck. Acta Otolaryngol 121: 103-109, 2001.
13. Hara M, Yanagihara T, and Kihara I. Urinary podocytes in primary focal segmental glomerulosclerosis. Nephron 89: 342-347, 2001.
14. Hirata M, Makibayashi K, Katsumata K, Kusano K, Watanabe T, Fukushima N, and Doi T. 22-Oxacalcitriol prevents progressive glomerulosclerosis without adversely affecting calcium and phosphorus metabolism in subtotally nephrectomized rats. Nephrol Dial Transplant 17: 2132-2137, 2002.
15. Hiromura K, Haseley LA, Zhang P, Monkawa T, Durvasula R, Petermann AT, Alpers CE, Mundel P, and Shankland SJ. Podocyte expression of the CDK-inhibitor p57 during development and disease. Kidney Int 60: 2235-2246, 2001.
16. Janssen U, Riley SG, Vassiliadou A, Floege J, and Phillips AO. Hypertension superimposed on type II diabetes in Goto-Kakizaki rats induces progressive nephropathy. Kidney Int 63: 2162-2170, 2003.
17. Kato S, Takeyama K, Kitanaka S, Murayama A, Sekine K, and Yoshizawa T. In vivo function of VDR in gene expression-VDR knockout mice. J Steroid Biochem Mol Biol 69: 247-251, 1999.
18. Kim YG, Alpers CE, Brugarolas J, Johnson RJ, Couser WG, and Shankland SJ. The cyclin kinase inhibitor p21CIP1/WAF1 limits glomerular epithelial cell proliferation in experimental glomerulonephritis. Kidney Int 55: 2349-2361, 1999.
19. Kim YH, Goyal M, Kurnit D, Wharram B, Wiggins J, Holzman L, Kershaw D, and Wiggins R. Podocyte depletion and glomerulosclerosis have a direct relationship in the PAN-treated rat. Kidney Int 60: 957-968, 2001.
20. Kriz W, Hosser H, Hahnel B, Simons JL, and Provoost AP. Development of vascular pole-associated glomerulosclerosis in the Fawn-hooded rat. J Am Soc Nephrol 9: 381-396, 1998.
21. Kriz W and Lemley KV. The role of the podocyte in glomerulosclerosis. Curr Opin Nephrol Hypertens 8: 489-497, 1999.
22. Lee TH and Pelletier J. Functional characterization of WT1 binding sites within the human vitamin D receptor gene promoter. Physiol Genomics 7: 187-200, 2001.
23. 3 leads to the induced differentiation of the myelomonocytic cell line U937. Genes Dev 10: 142-153, 1996.
24. Makibayashi K, Tatematsu M, Hirata M, Fukushima N, Kusano K, Ohashi S, Abe H, Kuze K, Fukatsu A, Kita T, and Doi T. A vitamin D analog ameliorates glomerular injury on rat glomerulonephritis. Am J Pathol 158: 1733-1741, 2001.
25. 3 on compensatory renal growth in the growing rat. Kidney Int 40: 212-218, 1991.
26. Megyesi J, Price PM, Tamayo E, and Safirstein RL. The lack of a functional p21 (WAF1/CIP1) gene ameliorates progression to chronic renal failure. Proc Natl Acad Sci USA.96: 10830-10835, 1999.
27. Mundel P and Shankland SJ. Podocyte biology and response to injury. J Am Soc Nephrol 13: 3005-3015, 2002.
28. 3 induces differentiation of a retinoic acid-resistant acute promyelocytic leukemia cell line (UF-1) associated with expression of p21(WAF1/CIP1) and p27(KIP1). Blood 93: 2225-2233, 1999.
29. 3 on the growth of the renal carcinoma cell line. Kidney Int 29: 834-840, 1986.
30. Nagata M, Shu Y, and Tomari S. Role of cell cycle molecules in the pathophysiology of glomerular epithelial cells. Microsc Res Tech 57: 203-207, 2002.
31. Norman AW, Roth J, and Orci L. The vitamin D endocrine system: steroid metabolism, hormone receptors, and biological response (calcium binding proteins). Endocr Rev 3: 331-366, 1982.
32. Pagtalunan ME, Miller PL, Jumping-Eagle S, Nelson RG, Myers BD, Rennke HG, Coplon NS, Sun L, and Meyer TW. Podocyte loss and progressive glomerular injury in type II diabetes. J Clin Invest Jan 99: 342-348, 1997.
33. 3 in experimental mesangial proliferative nephritis in rats. Kidney Int 60: 87-95, 2001.
34. 3 analog EB 1089 in NCI-929 myeloma cells is associated with induction of the cyclin-dependent kinase inhibitor p27. Exp Cell Res 254: 279-286, 2000.
35. 3. Transplant Proc 33: 2083-2084, 2001.
36. Petermann AT, Pippin J, Hiromura K, Monkawa T, Durvasula R, Couser WG, Kopp J, and Shankland SJ. Mitotic cell cycle proteins increase in podocytes despite lack of proliferation. Kidney Int 63: 113-122, 2003.
37. Pritchard-Jones K, Fleming S, Davidson D, Bickmore W, Porteous D, Gosden C, Bard J, Buckler A, Pelletier J, Housman D, van Heyningen V, and Hastie ND. The candidate Wilms tumour gene is involved in genitourinary development. Nature 346: 194-197, 1990.
38. Raats CJ, van den Born J, Bakker MA, Oppers-Walgreen B, Pisa BJ, Dijkman HB, Assmann KJ, and Berden JH. Expression of agrin, dystroglycan, and utrophin in normal renal tissue and in experimental glomerulopathies. Am J Pathol 156: 1749-1765, 2000.
39. Regele HM, Fillipovic E, Langer B, Poczewki H, Kraxberger I, Bittner RE, and Kerjaschki D. Glomerular expression of dystroglycans is reduced in minimal change nephrosis but not in focal segmental glomerulosclerosis. J Am Soc Nephrol 11: 403-412, 2000.
40. Remuzzi A, Puntorieri S, Alfano M, Macconi D, Abbate M, Bertani T, and Remuzzi G. Patho-physiologic implications of proteinuria in a rat model of progressive glomerular injury. Lab Invest 67: 572-579, 1992.
41. Rennke HG and Klein PS. Pathogenesis and significance of nonprimary focal and segmental glomerulosclerosis. Am J Kidney Dis 13: 443-456, 1989.
42. Sachs L. Applied Statistics. Berlin: Springer-Verlag, 1998, p. 364-367.
43. Safadi FF, Thornton P, Magiera H, Hollis BW, Gentile M, Haddad JG, Liebhaber SA, and Cooke NE. Osteopathy and resistance to vitamin D toxicity in mice null for vitamin D binding protein. J Clin Invest 103: 239-251, 1999.
44. Schiffer M, Bitzer M, Roberts IS, Kopp JB, ten Dijke P, Mundel P, and Bottinger EP. Apoptosis in podocytes induced by TGF-beta and Smad7. J Clin Invest 108: 807-816, 2001.
45. 3 on glomerulosclerosis in subtotally nephrectomized rats. Kidney Int 53: 1696-1705, 1998.
46. 3 analog, EB 1089, on G, cell cycle regulatory proteins in HL-60 cells. Int J Oncol 16: 315-320, 2000.
47. Steffes MW, Schmidt D, McCrery R, and Basgen JM. Glomerular cell number in normal subjects and in type 1 diabetic patients. Kidney Int 59: 2104-2113, 2001.
48. 3 in rat kidney: comparison with localization of parathyroid hormone and estradiol. Proc Natl Acad Sci USA 77: 1149-1153, 1980.
49. 3 in intestinal tract, stomach, kidney, skin, pituitary, and parathyroid. Science 206: 1188-1190, 1979.
50. 3 on the cell cycle genes, cyclin D1, p21 and p27 in MCF-7 cells. Mol Cell Endocrinol 142: 57-65, 1998.
51. Vogelmann SU, Nelson WJ, Myers BD, and Lemley KV. Urinary excretion of viable podocytes in health and renal disease. Am J Physiol Renal Physiol 285: F40-F48, 2003.
52. Wagner KD, Wagner N, Sukhatme VP, and Scholz H. Activation of vitamin D receptor by the Wilms tumor gene product mediates apoptosis of renal cells. J Am Soc Nephrol 12: 1188-1196, 2001.
53. Walters MR. Newly identified actions of the vitamin D endocrine system. Endocr Rev 13: 719-764, 1992.
54. Weibel ER. Stereological Methods for Biological Morphometry. London: Academic, 1997, vol. 1, p. 28.
55. Weibel ER. Stereological Methods: Theoretical Foundations. London: Academic, 1997, vol. 2, p. 64-65.